Despite the numerous advances in imaging technologies during the last decades, the diagnosis of pancreatobiliary disorders remain a challenge, particularly in the patient who present early or without bile
duct dilatation. A standard abdominal US (ultrasonography) and CT can be used to screen for and detect pancreatic and biliary disorders. However, the sensitivity of these methods even in expert hands varies
widely. The invasive imaging method ERCP (Endoscopic Retrograde Cholangiopancreatography) is considered the gold standard for diagnosis of pancreatobiliary disorders. EUS (Endoscopic Ultrasonography) is
without question the most important of the many innovation that have occurred in gastrointestinal endoscopy during the last decade. So, we have instituted this study which comprised 98 patients with pancreatic or biliary disorders+ Al) patients included in the study wenc qubjected to complete history and clinical examination, laboratory investigations including urine and stool analysis, complete blood picture, serum creatinine and blood urea, fasting and post prandial blood glucose level, liver ftmction tests ; serum
bilirubin both total and conjugated, alkaline phosphatase, aspartate transaminase, alanine transaminase, albumin level, prothrombin time and y -glutamyl transpeptidase . serum amylase levels before and 90 minutes
after the procedure of FRCP ; abdominal ultrasonography ; Computed tomography : Endoscopic Reterograde Cholangiopancreatography (ERCP) . Endoscopic Ultrasonography (EUS) and for some individual cases one
or more of the following investigations: histopathological examination of the biopsy thken by endoscopy or surgery Ind /or brush-cytology and pure pancreatit mice collection and estimation of (}'1CO3). |
